Tibet Aim Pharm Inc - Asset Resilience Ratio

Latest as of March 2026: 18.13%

Tibet Aim Pharm Inc (002826) has an Asset Resilience Ratio of 18.13% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥200.00 Million

≈ $29.27 Million USD Cash + Short-term Investments

Total Assets

CN¥1.10 Billion

≈ $161.45 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2023)

This chart shows how Tibet Aim Pharm Inc's Asset Resilience Ratio has changed over time. Check 002826 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Tibet Aim Pharm Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002826 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥200.00 Million	18.13%
Total Liquid Assets	CN¥200.00 Million	18.13%

Asset Resilience Insights

Good Liquidity Position: Tibet Aim Pharm Inc maintains a healthy 18.13% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Tibet Aim Pharm Inc Industry Peers by Asset Resilience Ratio

Compare Tibet Aim Pharm Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Tibet Aim Pharm Inc (2014–2023)

The table below shows the annual Asset Resilience Ratio data for Tibet Aim Pharm Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.00%	CN¥-2.00 ≈ $-0.29	CN¥927.74 Million ≈ $135.76 Million	-3.59pp
2019-12-31	3.59%	CN¥30.00 Million ≈ $4.39 Million	CN¥835.41 Million ≈ $122.25 Million	+3.73pp
2015-12-31	-0.14%	CN¥-570.74K ≈ $-83.52K	CN¥397.70 Million ≈ $58.20 Million	-0.96pp
2014-12-31	0.82%	CN¥2.20 Million ≈ $321.93K	CN¥268.42 Million ≈ $39.28 Million	--

pp = percentage points

About Tibet Aim Pharm Inc

SHE:002826 China Drug Manufacturers - Specialty & Generic

Market Cap

$449.78 Million

CN¥3.07 Billion CNY

Market Cap Rank

#12648 Global

#3673 in China

Share Price

CN¥16.12

Change (1 day)

+0.06%

52-Week Range

CN¥15.01 - CN¥25.74

All Time High

CN¥32.76